VOTING AGREEMENTVoting Agreement • May 30th, 2008 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
This VOTING AGREEMENT (this “Agreement”) is made and entered into as of May 27, 2008, by and between OncoGenex Technologies Inc., a corporation existing under the federal laws of Canada (“OncoGenex”), and the signatory hereto (the “Stockholder”). Capitalized terms used and not defined herein have the same meaning as in the Arrangement Agreement, dated as of the date hereof (as such agreement may hereafter be amended or modified from time to time, the “Arrangement Agreement”), by and between Sonus Pharmaceuticals, Inc., a Delaware corporation (“Sonus”), and OncoGenex.
VOTING AGREEMENTVoting Agreement • May 30th, 2008 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • British Columbia
This VOTING AGREEMENT (this “Agreement”) is made and entered into as of May 27, 2008, by and between Sonus Pharmaceuticals, Inc., a Delaware corporation (“Sonus”), and the signatory hereto (the “Securityholder”). Capitalized terms used and not defined herein have the same meaning as in the Arrangement Agreement, dated as of the date hereof (as such agreement may hereafter be amended or modified from time to time, the “Arrangement Agreement”), by and between Sonus and OncoGenex Technologies Inc., a corporation existing under the federal laws of Canada (“OncoGenex”).
ARRANGEMENT AGREEMENTArrangement Agreement • May 30th, 2008 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • British Columbia
THIS AGREEMENT WITNESSETH THAT in consideration of the respective covenants and agreements herein contained and for other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged by each party), the parties hereby covenant and agree as follows:
